Meningitis outbreak spreads to Ohio, too
The rare fungal meningitis outbreak that has killed seven people and sickened more than 60 across several states has been found in Ohio.
The Centers for Disease Control and Prevention said on Saturday that it has confirmed one case in Ohio, but it did not say where. Ohio's Health Department confirmed there was one documented illness, and it was gathering information about the case.
The CDC has said the outbreak may have been caused by a steroid made by a specialty pharmacy in Massachusetts, where inspectors found at least one sealed vial that was contaminated. It's not yet clear how the fungus got into the steroid, which is commonly used to treat back pain.
The CDC said facilities in 23 states received the steroid implicated in the outbreak, including Pennsylvania, Maryland, New York, Ohio and West Virginia.
The Pennsylvania Department of Health said no cases of illness have been reported in the state, but the drug associated with the outbreak was used at Allegheny Pain Management in Altoona and South Hills Pain and Rehab Associates locations in Jefferson Hills, Bethel Park, Monessen and Brentwood.
Dr. Michael Drass, an Altoona physician, says he has pulled all drugs shipped by the specialty pharmacy.
Drass, of Allegheny Pain Management says he's also re-evaluating whether to rely on compounding pharmacies for the medicines he uses to treat his patients.
South Hills Pain and Rehab Associates has said in a statement that it is attempting to contact each patient who received the drug and has reached most of them by phone. The rest will receive a certified letter.
Pennsylvania health officials said there have been no reports of death or illness in the state so far.
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments â either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.